D3 Bio is based in Wuxi, China. It has raised $308M in total funding. Latest round: Series B.
D3 Bio is based in Wuxi, China. D3 Bio has raised $308M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in December 2025. The round record for D3 Bio runs through 2025; nothing later has been disclosed. Investors on record include IDG Capital, SongQing Capital, WuXi AppTec's Corporate Venture Fund, Temasek, HSG, MPCi and 1 others. 7 distinct backers are named across the disclosed rounds.
D3 Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Wuxi below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026